Funder
Agence Nationale de la Recherche
Publisher
Springer Science and Business Media LLC
Reference20 articles.
1. Résumé des caractéristiques du produit - DAPTOMYCINE ACCORD 350 mg, poudre pour solution injectable/pour perfusion - Base de données publique des médicaments [Internet]. [cited 2023 Jan 24]. Available from: https://base-donnees-publique.medicaments.gouv.fr/affichageDoc.php?specid=69082149&typedoc=R
2. Benvenuto M, Benziger DP, Yankelev S, Vigliani G. Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers. Antimicrob Agents Chemother. 2006;50:3245–9.
3. Jones TW, Jun AH, Michal JL, Olney WJ. High-dose daptomycin and clinical applications. Ann Pharmacother. 2021;55:1363–78.
4. Safdar N, Andes D, Craig WA. In vivo pharmacodynamic activity of daptomycin. Antimicrob Agents Chemother. 2004;48:63–8.
5. Falcone M, Russo A, Cassetta MI, Lappa A, Tritapepe L, d’Ettorre G, et al. Variability of pharmacokinetic parameters in patients receiving different dosages of daptomycin: is therapeutic drug monitoring necessary? J Infect Chemother. 2013;19:732–9.